Israeli biopharmaceutical firm Eloxx raises $24 million
Eloxx Pharmaceuticals Ltd, a clinical stage company developing drugs for genetic diseases, raised $24 million in an investment round led by Catalyst CEL Fund and Israeli life sciences venture capital fund Pontifax
Globes English – Drug developer Eloxx Pharmaceuticals raises $24m
Eloxx Pharmaceuticals has raised $24 million in a series C nancing round led by Pontifax and with the participation of Catalyst CEL – Israeli Chinese fund, Quark Venture Inc. and…